Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BDTX | BLACK DIAMOND THERAPEUTICS INC | $136.17M | $70.00M | $21.84M | $21.50M | $0.38 | N/A | N/A | N/A | N/A | 2026-03-18 | ||
| HTFL | HEARTFLOW INC | $2.40B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2026-02-12 | ||
| FBRX | FORTE BIOSCIENCES INC | $401.36M | $0.00 | -$51.69M | -$51.74M | -$0.14 | N/A | N/A | N/A | N/A | |||
| W | WAYFAIR INC | $11.85B | $12.24B | $105.00M | -$325.00M | -$2.57 | 3.35% | -1.21% | N/A | N/A | 2026-02-19 | ||
| NBP | NOVABRIDGE BIOSCIENCES | $394.49M | $0.00 | N/A | -$24.54M | -$0.30 | -100.00% | N/A | N/A | N/A | |||
| CNTX | CONTEXT THERAPEUTICS INC | $211.32M | $0.00 | -$26.32M | -$26.44M | -$0.24 | N/A | N/A | N/A | N/A | 2026-03-25 | ||
| LAKE | LAKELAND INDUSTRIES INC | $93.84M | $193.46M | -$24.61M | -$37.54M | -$4.45 | 27.42% | 5.19% | N/A | N/A | |||
| SYRE | SPYRE THERAPEUTICS INC | $2.49B | $0.00 | -$148.98M | -$148.97M | -$2.03 | N/A | N/A | N/A | N/A | 2026-02-26 | ||
| BETA | BETA TECHNOLOGIES INC | $4.13B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2026-03-26 | ||
| ZYME | ZYMEWORKS INC | $1.73B | $134.48M | -$43.27M | -$63.43M | -$0.85 | 116.21% | 39.84% | N/A | N/A | |||
| CSTL | CASTLE BIOSCIENCES INC | $1.02B | $343.53M | $24.00M | -$12.24M | -$0.41 | 10.15% | 40.39% | N/A | N/A | 2026-03-04 | ||
| LBRX | LB PHARMACEUTICALS INC | $535.58M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2026-02-25 | ||
| CEVA | CEVA INC | $496.45M | $107.53M | -$1.48M | -$11.28M | -$0.46 | 5.55% | 1.36% | N/A | N/A | 2026-02-17 | ||
| ZGN | ERMENEGILDO ZEGNA NV | $2.47B | $2.23B | $454.93M | $57.69M | N/A | 6.77% | N/A | N/A | N/A | 2026-03-26 | ||
| MARA | MARA HOLDINGS INC | $3.13B | $919.17M | $1.84B | $926.69M | $2.89 | 53.51% | 241.09% | 207.45% | N/A | 2026-03-04 | ||
| KRRO | KORRO BIO INC | $115.46M | $7.37M | -$82.74M | -$88.42M | -$9.41 | N/A | -25.32% | N/A | N/A | |||
| ABVX | ABIVAX SA | $8.28B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2026-03-23 | ||
| AKA | AKA BRANDS HOLDING CORP | $117.71M | $595.28M | $18.34M | -$26.29M | -$2.46 | 5.44% | N/A | N/A | N/A | |||
| CHYM | CHIME FINANCIAL INC | $8.14B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2026-02-25 | ||
| TYRA | TYRA BIOSCIENCES INC | $1.64B | $0.00 | -$111.13M | -$111.68M | -$1.87 | N/A | N/A | N/A | N/A | 2026-03-25 | ||
| CARL | CARLSMED INC | $306.08M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2026-02-19 | ||
| CLFD | CLEARFIELD INC | $421.68M | $150.13M | $428.00k | -$8.05M | -$0.58 | 19.56% | 10.03% | N/A | N/A | |||
| NEXN | NEXXEN INTERNATIONAL LTD | $175.82M | $376.35M | $112.03M | $39.36M | $1.34 | 7.80% | N/A | 3,250.00% | N/A | 2026-03-11 | ||
| IMTX | IMMATICS NV | $1.14B | $98.56M | -$124.76M | -$134.75M | -$1.05 | -22.30% | 26.18% | N/A | N/A | 2026-03-25 | ||
| CGTX | COGNITION THERAPEUTICS INC | $90.92M | $0.00 | -$27.74M | -$27.99M | -$0.48 | N/A | N/A | N/A | N/A | 2026-04-01 | ||
| CRVO | CERVOMED INC | $43.21M | $6.16M | -$25.58M | -$25.58M | -$2.90 | -38.81% | N/A | N/A | N/A | |||
| KYMR | KYMERA THERAPEUTICS INC | $5.59B | $43.73M | -$286.52M | -$295.12M | -$3.60 | -50.05% | 13.63% | N/A | N/A | 2026-02-19 | ||
| SLDB | SOLID BIOSCIENCES INC | $507.97M | $0.00 | -$162.61M | -$167.14M | -$2.51 | N/A | N/A | N/A | N/A | |||
| TERN | TERNS PHARMACEUTICALS INC | $3.25B | $0.00 | -$93.60M | -$94.44M | -$1.02 | N/A | N/A | N/A | N/A | 2026-03-31 | ||
| PCVX | VAXCYTE INC | $7.24B | $0.00 | -$637.36M | -$657.20M | -$4.84 | N/A | N/A | N/A | N/A | 2026-03-02 | ||
| CGEM | CULLINAN THERAPEUTICS INC | $728.41M | $0.00 | -$216.39M | -$219.46M | -$3.06 | N/A | N/A | N/A | N/A | 2026-03-05 | ||
| GHI | GREYSTONE HOUSING IMPACT INVESTORS LP | $182.29M | $92.98M | $65.74M | $8.36M | $0.17 | -0.95% | 10.09% | -72.58% | -23.81% | 2026-02-19 | ||
| GHRS | GH RESEARCH PLC | $963.94M | $0.00 | -$42.05M | -$42.92M | -$0.74 | N/A | N/A | N/A | N/A | 2026-02-26 | ||
| OLMA | OLEMA PHARMACEUTICALS INC | $1.81B | $0.00 | -$148.38M | -$149.96M | -$1.76 | N/A | N/A | N/A | N/A | 2026-03-02 | ||
| HELP | CYBIN INC | $146.49M | $0.00 | -$70.85M | -$71.04M | -$3.20 | N/A | N/A | N/A | N/A | |||
| SGMT | SAGIMET BIOSCIENCES INC | $197.73M | $0.00 | -$57.52M | -$57.67M | -$1.78 | N/A | N/A | N/A | N/A | |||
| NTSK | NETSKOPE INC | $5.16B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2026-03-12 | ||
| USAR | USA RARE EARTH INC | $3.12B | $0.00 | -$253.57M | -$254.15M | -$2.88 | N/A | N/A | N/A | N/A | 2026-03-30 | ||
| MBX | MBX BIOSCIENCES INC | $1.72B | $0.00 | -$80.12M | -$80.50M | $7.68 | N/A | N/A | N/A | N/A | 2026-03-23 | ||
| LUCK | LUCKY STRIKE ENTERTAINMENT CORP | $1.01B | $1.24B | $372.89M | -$94.29M | -$0.67 | 4.94% | N/A | N/A | N/A | |||
| GLUE | MONTE ROSA THERAPEUTICS INC | $1.27B | $181.54M | $30.28M | $20.95M | $0.32 | 1,112.27% | N/A | N/A | N/A | 2026-03-12 | ||
| CRVS | CORVUS PHARMACEUTICALS INC | $1.55B | $0.00 | -$14.98M | -$15.08M | -$0.17 | N/A | N/A | N/A | N/A | 2026-03-05 | ||
| BNTX | BIONTECH SE | $26.15B | $3.67B | -$69.88M | -$664.65M | -$2.76 | 9.80% | 79.99% | N/A | N/A | 2026-03-10 | ||
| LXEO | LEXEO THERAPEUTICS INC | $530.62M | $0.00 | -$102.80M | -$104.97M | -$2.70 | N/A | N/A | N/A | N/A | 2026-03-16 | ||
| VOYG | VOYAGER TECHNOLOGIES INC | $1.65B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2026-03-23 | ||
| OKLO | OKLO INC | $10.66B | $0.00 | -$77.20M | $413.43M | -$0.54 | N/A | N/A | N/A | N/A | |||
| HOWL | WEREWOLF THERAPEUTICS INC | $31.16M | $0.00 | -$65.24M | -$72.84M | -$1.62 | -100.00% | N/A | N/A | N/A | 2026-03-19 | ||
| ORIC | ORIC PHARMACEUTICALS INC | $1.03B | $0.00 | -$134.07M | -$135.27M | -$1.73 | N/A | N/A | N/A | N/A | 2026-03-24 | ||
| UPB | UPSTREAM BIO INC | $1.59B | $2.80M | -$121.50M | -$122.77M | $10.69 | 26.82% | N/A | N/A | N/A | 2026-03-11 | ||
| KYTX | KYVERNA THERAPEUTICS INC | $333.73M | $0.00 | -$156.09M | -$160.99M | -$3.73 | N/A | N/A | N/A | N/A | |||
| ACRV | ACRIVON THERAPEUTICS INC | $53.33M | $0.00 | -$79.45M | -$81.75M | -$2.12 | N/A | N/A | N/A | N/A | |||
| RAPP | RAPPORT THERAPEUTICS INC | $1.26B | $0.00 | -$95.06M | -$97.70M | -$2.26 | N/A | N/A | N/A | N/A | 2026-03-17 | ||
| CBIO | CRESCENT BIOPHARMA INC | $134.90M | $0.00 | -$54.74M | -$55.96M | -$21.20 | -100.00% | -100.00% | N/A | N/A | |||
| APGE | APOGEE THERAPEUTICS INC | $4.43B | $0.00 | -$248.87M | -$253.67M | -$4.38 | N/A | N/A | N/A | N/A | 2026-03-10 | ||
| IDYA | IDEAYA BIOSCIENCES INC | $2.92B | $214.83M | -$156.70M | -$160.74M | -$1.90 | 5,377.66% | 88.75% | N/A | N/A | 2026-03-31 | ||
| NRIX | NURIX THERAPEUTICS INC | $1.70B | $83.98M | -$244.84M | -$264.46M | -$3.05 | 53.95% | 36.35% | N/A | N/A | |||
| NAVN | NAVAN INC | $2.75B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| PEPG | PEPGEN INC | $337.55M | $0.00 | -$92.73M | -$93.56M | -$2.82 | N/A | N/A | N/A | N/A | 2026-03-19 | ||
| AIRG | AIRGAIN INC | $55.96M | $54.74M | -$2.23M | -$5.95M | -$0.50 | -1.53% | 2.37% | N/A | N/A | 2026-02-19 | ||
| ANRO | ALTO NEUROSCIENCE INC | $466.00M | $0.00 | -$58.57M | -$62.26M | -$2.29 | N/A | N/A | N/A | N/A | 2026-03-20 | ||
| TRVI | TREVI THERAPEUTICS INC | $1.47B | $0.00 | -$45.74M | -$45.86M | -$0.37 | N/A | N/A | N/A | N/A | 2026-03-25 | ||
| CYRX | CRYOPORT INC | $465.64M | $190.26M | $106.58M | $59.58M | $1.17 | 10.25% | 36.89% | N/A | N/A | 2026-03-11 | ||
| IMRX | IMMUNEERING CORP | $306.06M | $0.00 | -$61.80M | -$62.50M | -$1.79 | N/A | N/A | N/A | N/A | 2026-03-11 | ||
| CTMX | CYTOMX THERAPEUTICS INC | $960.70M | $113.63M | $33.92M | $28.02M | $0.41 | -10.26% | 13.00% | 141.18% | N/A | 2026-03-04 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.